As we prepare to announce details of a new phase of prior authorization for specialty drug claims later this summer, now is a good time to recap our journey as well as next steps.
GreenShield and OkRx, a technology solutions provider, have been awarded a grant from the Canadian Medical Association (CMA) Foundation, Scotiabank, and MD Financial Group for the launch of electronic prior authorization (ePA) in Canada.
In the last of our six-part series examining prior authorization (PA) in Canada vs. the U.S., we explore what is driving the need for electronic prior authorization (ePA) and how ePA improves the claims process and is more cost effective and efficient than the current manual process.
Follow our new Facebook page, where we will be providing resources and insight into the prior authorization claims process for patients.
In the fifth of our six-part series examining the prior authorization (PA) process in Canada vs. the U.S. we address the importance of the continuity of patient care.
Changes in prior authorization are now coming to the U.S. at the federal level. What does this mean for Canada?
The Simplify Prior Authorization initiative is an advocate for education about prior authorization (PA) and improvement in current prior authorization practices and processes. If your organization is interested in finding out more, getting involved, or in sponsorship of this important initiative, please contact us via the link below.